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Acetylcholinesterase-capped mesoporous silica nanoparticles 
controlled by presence of inhibitors. 
Lluís Pascual,[a,b,c] Sameh El Sayed,[a,b,c] María D. Marcos,[a,b,c] Ramón Martínez-Máñez*[a,b,c] and Félix 
Sancenón[a,b,c]
Abstract: Two different acetylcholinesterase (AChE)-capped 
mesoporous silica nanoparticles (MSNs), S1-AChE and S2-AChE, 
were prepared and characterized. MSNs were loaded with 
rhodamine B and the external surface was functionalized with either 
pyridostigmine derivative P1 (to yield solid S1) or neostigmine 
derivative P2 (to obtain S2). The final capped materials were 
obtained by coordinating grafted P1 or P2 with AChE’s active sites 
(to give S1-AChE and S2-AChE, respectively). Both materials were 
able to release rhodamine B in the presence of 
diisopropylfluorophosphate (DFP) or neostigmine in a concentration-
dependent manner via the competitive displacement of AChE 
through DFP and neostigmine coordination with the AChE`s active 
sites. The responses of S1-AChE and S2-AChE were also tested 
with other enzyme inhibitors and substrates. These studies suggest 
that S1-AChE nanoparticles can be used for the selective detection 
of nerve agent simulant DFP and paraoxon.  
Introduction 
In the last few decades, nanotechnology has provided numerous 
examples of abiotic devices capable of performing certain 
operations in response to minor changes in the environment in 
which the nanomaterial is located. One appealing concept inside 
the realm of these “smart nanodevices” is the design of 
controlled release nanoparticles that contain “molecular gates”.[1] 
These gated nanodevices are usually formed by three subunits; 
i.e., (i) a suitable inorganic porous scaffold; (ii) a payload that is 
loaded onto the porous network; and (iii) a molecular or 
supramolecular capping ensemble, grafted onto the outer 
surface of the support, which allows cargo release upon the 
application of an external stimulus (e.g., light, pH, temperature, 
magnetic fields, presence of certain (bio)chemical species, 
etc.).[2–5] 
 One of the supports that has been extensively used to 
prepare gated materials is mesoporous silica nanoparticles 
(MSNs) owing to some of their properties, such as relatively 
well-known functionalization chemistry (using trialkoxysilane 
derivatives), high stability and presence of finely-tuned pores 
within the nanometric range (typically 2–3 nm).[6] While dealing 
with the payload, a myriad of chemical and biochemical 
molecules, e.g., drugs, biomolecules, redox active species and 
dyes/fluorophores, has been encapsulated onto MSNs-based 
supports.[7–11] 
 These gated materials have found notable applications in 
controlled releases in the biotechnological and biomedical 
fields,[12] especially in the drug delivery area for the potential 
treatment of different diseases.[13,14] Gated materials have also 
been applied in sensing and recognition protocols.[15] For the 
latter application, the underlying idea is that the coordination or a 
reaction of a certain analyte with the capping unit can modulate 
the delivery of a previously stored reporter, usually a dye or 
fluorophore, from the pores to the solution, which gives rise to a 
simple-to-detect chromo-fluorogenic signal. 
 Form another point of view, the implementation of 
enzymes in gated materials has attracted much attention in 
recent years. For instance, enzymes can be used as triggers to 
induce the chemical degradation of certain biomolecules used 
as gates to allow cargo release.[16–18] In this scenario, several 
examples of gated materials capable of delivering an entrapped 
payload in the presence of esterases, amidases, azoreductases, 
glycosidases and other enzymes have been reported.[19–23] 
These materials can potentially find applications in personalized 
biomedicine by taking advantage of the overexpression of 
certain enzymes in target diseases, which triggers pore opening 
and cargo release in only target tissues or organs.[24] 
Enzymes have also been used recently as capping 
subunits. In this specific use of enzymes, Martínez-Máñez and 
co-workers used cyclodextrin-modified glucose oxidase to close 
the pores of mesoporous silica nanoparticles, loaded with a dye 
and functionalized with a benzimidazole derivative, through the 
formation of benzimidazole-cyclodextrin inclusion 
supramolecular complexes.[25] In the presence of glucose, the 
capping enzyme produced gluconic acid that induced 
benzimidazole protonation, dethreading of the supramolecular 
complex and dye release. In a second example, Lu and co-
workers grafted glucosamine derivatives onto the external 
surface of mesoporous silica nanoparticles. Then pores were 
capped with glucose oxidase through the coordination of 
glucosamine with the enzyme’s active site. In the presence of 
glucose, marked delivery of an entrapped dye was observed due 
to preferential glucose binding with the glucose oxidase active 
site and subsequent enzyme displacement from the surface.[26] 
Along this line, Villalonga and co-workers prepared mesoporous 
silica nanoparticles loaded with a dye and the external surface 
was functionalized with a boronic acid derivative. The capped 
material was obtained upon the addition of lactose-
functionalized esterase through the formation of boronate esters 
between disaccharides and the grafted boronic acids.[27] The 
entrapped dye was released in the presence of glucose or ethyl 
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butyrate. Ren et al also used glucose oxidase as caps, in which 
case the opening protocol was related with the hydrolysis of the 
enzyme by a protease.[28] Very recently, Bein and co-workers 
prepared mesoporous silica nanoparticle loaded with fluorescein 
and capped with carbonic anhydrase (which binds reversibly 
through its active center to aryl sulfonamide groups grafted onto 
the nanoparticles surface).[29] These nanoparticles delivered its 
cargo at pH 5.5 due to sulfonamide protonation with the 
subsequent detachment of the capping enzyme. On the other 
hand, other hybrid materials containing enzymes (adsorbed[30] or 
grafted[31]) onto the external surface of the inorganic scaffolds 
have been described. In these examples, enzymes are not used 




Scheme 1. Schematic representation of the opening mechanism of solid S1-
AChE (grafted with P1) and solid S2-AChE (grafted with P2). 
 
After taking into account the above-mentioned facts and 
our interest in developing gated nanomaterials for applications in 
controlled delivery and recognition/sensing protocols,[32] we 
report herein the use of acetylcholinesterase (AChE) as a cap 
for the development of nanodevices that are expected to release 
their cargo in the presence of AChE inhibitors. For this purpose, 
we selected silica mesoporous nanoparticles as the inorganic 
scaffold and loaded pores with rhodamine B. In a second step, 
the external surface of the loaded nanoparticles was 
functionalized with two different derivatives of reversible AChE 
inhibitors; i.e. pyridostigmine and neostigmine (P1 and P2 in 
Scheme 1). Finally, addition of AChE induced pore capping by 
coordinating P1 and P2 with the enzyme’s active sites (to obtain 
S1-AChE and S2-AChE, respectively). The AChE-capped solids 
were expected to show “zero release”, but would deliver the 
cargo in the presence of other inhibitors with more affinity to the 
AChE enzyme (see Scheme 1). We selected the AChE enzyme 
because this is a well-studied enzyme whose inhibitors (i.e. 
chemical warfare agents, neuroactive drugs or pesticides) are 
substances of interest. In fact capped solids S1-AChE and S2-
AChE can be potentially used as probes for the selective 
detection of diisopropylfluorophosphate (DFP) or paraoxon, 
(vide infra). A preliminary communication related with the 
performance of solid S1-AChE has been recently published by 
us.[33] 
Results and Discussion 
Synthesis of gated nanoparticles. Two different gated 
materials, S1-AChE and S2-AChE, were prepared using MSNs 



































Scheme 2. a) The synthetic protocols used to prepare the P1 and P2 
derivatives and the chemical structures of pyridostigmine and neostigmine. b) 
The chemical structures of the substrates and inhibitors used herein with 
solids S1-AChE and S2-AChE. 
 
MSNs were synthesized in alkaline media following well-
known procedures that use n-cetyltrimethylammonium bromide 
(CTAB) as the directing agent for the condensation of inorganic 

































































































































was washed and the surfactant was subsequently removed by 
calcination. Then the pores of MSNs were loaded with 
fluorophore rhodamine B by stirring a suspension of 
nanoparticles in a concentrated acetonitrile solution of the dye 
(solid S0). Afterward P1 and P2 were grafted onto the external 
surface of the loaded nanoparticles, which yielded solids S1 and 
S2. Final gated nanoparticles S1-AChE and S2-AChE were 
prepared by suspending S1 and S2 in an aqueous (TRIS pH 
8.0) solution of AChE for 30 min. In this step, AChE was 
immobilized onto the external surface of the nanoparticles 
through the reversible interaction of the enzyme’s active site with 
the grafted P1 and P2 inhibitors with subsequent pore capping. 
P1 is a derivative of pyridostigmine and was prepared by a 
two-step procedure. In the first step, 3-hydroxypyridine (1a) was 
reacted with (3-isocyanatopropyl)triethoxysilane (1b), which 
yielded carbamate derivative 1c. In a second step, the nitrogen 
atom of the pyridine moiety in 1c was quaternized with 
methyliodide to yield P1 (see Scheme 2). A similar two-step 
synthetic protocol was used for the preparation of P2, which is a 
derivative of neostigmine, another reversible inhibitor of AChE. 
In this case, 3-(dimethylamino)phenol (2a) was reacted with (3-
isocyanatopropyl)triethoxysilane (1b) to yield carbamate 2b. 
Compound P2 was obtained after reacting 2b with methyl iodide 
(see Scheme 2).  
 
Materials characterization. MSNs and solids S1 and S2 were 
characterized by powder X-ray diffraction (PXRD), transmission 
electron microscopy (TEM), N2 adsorption-desorption isotherms, 















Figure 1. Left: The powder X-ray patterns of (a) as-made MSNs, (b) calcined 
MSNs, (c) solid S1, (d) solid S2. Right: The TEM images of (e) calcined MSNs, 
(f) solid S1; (g) solid S2. 
 
Figure 1 shows the PXRD patterns of MSNs as made (1a), 
the calcined MSNs (1b) and solids S1 (1c) and S2 (1d). The 
PXRD of the as-made MSNs showed four low-angle peaks, 
typical of a hexagonal-ordered array of pores that can be 
indexed as (100), (110), (200) and (210) Bragg reflections. A 
shift of the (100) peak and a remarkable broadening of the other 
reflections in the calcined MSNs was observed and ascribed to 
the further condensation of the silanol groups in the calcination 
step. For solids S1 and S2, the reflection (100) remained and 
indicated that the mesoporous structure was preserved in these 
solids despite filling pores with rhodamine B and anchoring the 
P1 and P2 functionalities on the nanoparticles’ surface. Figure 1 
shows the representative TEM images of the calcined MSNs 
(1e) and solids S1 (1f) and S2 (1g). Here it can be seen that S1 
and S2 preserve the spherical shape of the calcined 
nanoparticles, and have a similar average diameter of ca. 100 ± 
8 nm. In addition, the typical porosity associated with this type of 
inorganic support can be observed in the three materials.  
N2 adsorption-desorption studies were also carried out of 
the calcined MSNs and of both S1 and S2 (see Figure 2). The 
calcined MSNs showed a typical type IV curve, which is 
characteristic of this mesoporous support. The curve reveals the 
typical adsorption step at intermediate P/P0 values (0.1–0.3) in 
relation to the nitrogen condensation inside mesopores. The 
pore diameter distribution (PSD) of this sample was calculated 
by the Barret-Joyner-Halenda (BJH) method. A narrow BJH pore 
distribution and the absence of a hysteresis loop within this 
interval suggest the existence of uniform cylindrical mesopores 
(pore diameter of 2.45 nm and pore volume of 0.33 cm3 g–1, 
calculated on the adsorption branch of the isotherm). The 
application of the Brunauer–Emmett–Teller (BET) model gave a 
value of 747.5 m2 g–1 for the total specific surface. As could be 
seen in Table 1, the surface area and pore volume of solid S1 
are smaller than that of S2. Taking into account the fact that 
experimental procedure used to prepare both solids is the same, 
the differences in surface area and pore volume measured could 
be ascribed to the different chemical structures of the grafted 
inhibitors P1 and P2. At this respect, both inhibitors are of similar 
sizes and have a positive charge. The main difference arises 
from the fact that in P1 the positive charge is located in a 
nitrogen atom of a pyridine heterocycle whereas in P2 is located 
in a nitrogen atom directly linked to a benzene ring. The more 
planar P1 structure could induce the formation of a denser 
monolayer in the outer surface of S1 than that obtained in S2 
upon P2 grafting. The formation of different monolayers was 
reflected in the quantities of P1 and P2 grafted (0.93 mmol g-1 
SiO2 for S1 and 0.48 mmol g
-1 SiO2 for S2) in the outer surface 
of both solids. Taking into account these values, the steric 
crowding around the pores of S1 is higher than that of S2. As a 
consequence, the leaching of rhodamine B from the inner of the 
pores in S1 is more disabled when compared to that in S2. 
Taking into account these facts, the filling of the pores in S1 is a 
little bit more efficient that in S2 and, as a consequence, the 
surface area and pore volumes measured are smaller. 
 
 
Table 1. The BET-specific surface values, pore volumes, and pore sizes 



















MCM-41 747.5 2.45 0.33 
S1 65.9 - 0.03 
S2 137 - 0.10 
[a,b] Pore volumes and pore sizes were associated with only intraparticle 
mesopores. 






















Figure 2. The N2 adsorption-desorption isotherms for (a) the calcined MCM-41 
nanoparticles, (b) S2 and (c) S1. 
 
The N2 adsorption-desorption isotherms of solids S1 and 
S2 are typical of mesoporous systems with filled mesopores, 
and both the adsorbed N2 volume and the specific surface area 
drastically dropped (see Table 1). This reduction in the BET 
surface, compared with that of the MCM-41 starting material, 
was ascribed to loading pores with rhodamine B and to 
functionalizing the surface with P1 and P2. 
Finally, the organic matter content of both rhodamine B 
and P1/P2 in nanoparticles S1 and S2 was determined by 
combining thermogravimetric and elemental analysis data. The 
results are summarized in Table 2. 
 















S1 0.93 0.012 25.1 
S2 0.48 0.034 17.6 
 
The final solids, S1-AChE and S2-AChE were prepared by 
suspending S1 or S2 in an aqueous solution of AChE (TRIS 
buffer at pH 8.0) for 30 min (see the Experimental section for 
further details). Both final capped nanoparticles were prepared 
in small quantities and, for this reason, it was not possible to 
carry out a complete characterization of the solids. However, the 
UV-visible studies of the solution before and after the capping 
process allowed us to estimate that amounts of 250 ± 40 and 
200 ± 20 µmols g-1AChE attached in S1-AChE and S2-AChE, 
respectively. 
The capping process and enzyme immobilization were 
also followed by measuring AChE activity using Ellman’s assay 
(see Figure 3 and the Experimental section for details) before 
and after attaching AChE onto the external surface of the solids. 
Before grafting, AChE activity was 106.41 U mg-1, whereas this 
activity dropped to 1.97 U mg-1 and 2.89 U mg-1 for S1-AChE 
and S2-AChE, respectively, after immobilization. This reduction 
in enzyme activity was attributed to AChE immobilization on the 
surface by the interaction of the enzyme’s active sites with the 
grafted inhibitors. The detected low residual enzyme activity was 
tentatively ascribed to either (i) the small amounts of enzyme 
adsorbed physically onto the external surface of MSNs and/or 
(ii) presence of two active sites in AChE, which were perhaps 


















Figure 3. Absorbance at 412 nm which corresponds to the TNB
2-
 formed in 
the Ellman’s assay for the AChE activity measurement in nanoparticles S1-
AChE and S2-AChE. 
 
Dye delivery studies in the presence of AChE 
inhibitors:  As stated above, the presence of inhibitors with 
more affinity to ACHE than P1 or P2 was expected to induce a 
displacement of the enzyme from the nanoparticles, with the 
subsequent rhodamine B release. In a first step, uncapping 
studies were carried out with diisopropylfluorophosphate (DFP) 
and neostigmine. DFP is a quasi-irreversible AChE inhibitor 
commonly used as a nerve agent mimic, while neostigmine is a 
reversible AChE inhibitor used to treat myasthenia gravis. The 
main differences between DFP and neostigmine, in relation to 
their interaction with AChE, are associated with both the 
different coordination ability to the enzyme and the inhibition 
mechanism. In line with this, the half maximal inhibitory 
concentration (IC50) of DFP is 120 nM,
[35] whereas the value for 
neostigmine is 2 nM. These values reflected the better affinity of 
neostigmine, compared with DFP, to the AChE active sites. 
Moreover, organophosphate-based inhibitors, such as DFP, 
tend to covalently attach to the serine residue of the enzyme 
active site to form a very stable complex that can remain 
unaltered for hours or even days. When dealing with carbamate-
based inhibitors, e.g., neostigmine, their mode of interaction with 
AChE is similar to that of acetylcholine, but with slower kinetics 
(i.e., hydrolysis will take from minutes to hours).[36] 
In a typical experiment, 750 µg of S1-AChE were 
suspended in TRIS buffer (pH 8.0) and the resulting suspension 
was divided into three equal fractions. Two fractions were diluted 
with TRIS buffer, and DFP or neostigmine was added (a final 
DFP and neostigmine concentration of 10 mM). The other 

































fraction, which acted as a blank, was filled with MilliQ water. The 
same procedure was repeated for the S2-AChE nanoparticles. 
All the suspensions were stirred at room temperature, aliquots 
were extracted at the scheduled times and the solid was 
removed by centrifugation. Dye delivery to the bulk solution was 
easily detected by monitoring the emission band of rhodamine B 
in the solution at 572 nm upon excitation at 555 nm. The 
obtained cargo release profiles are shown in Figure 4. Table 3 




Figure 4. Kinetics of the release of rhodamine B from solids S1-AChE and S2-
AChE in the absence ( blank) and presence of DFP () and neostigmine 
(▲). 
 
As seen in Figure 4, in the absence of DFP or neostigmine, 
a poor rhodamine B release from solid S1-AchE occurred (less 
than 5% of the maximum dye delivered after 5 min and ca. 20% 
after 90 min). This partial dye delivery observed in the absence 
of DFP and neostigmine was ascribed to the fact that P1 (as a 
pyridostigmine) is a reversible inhibitor of the AChE enzyme. As 
a result, a slow enzymatic hydrolysis of P1 may happen with 
time, and the subsequent detachment of AChE from the solid 
surface and rhodamine B release can occur. However, when 
DFP or neostigmine was present, a remarkable rhodamine B 
release was observed (ca. 80% of the maximum dye delivered 
after 10 min). The release of the rhodamine B entrapped inside 
the pores of solid S1-AChE was attributed to a preferential 
coordination of DFP and neostigmine with the active sites of the 
AChE enzyme; i.e., both the used inhibitors (IC50 of 120 and 2 
nM for DFP and neostigmine, respectively) displayed stronger 
interactions with AChE than that shown by pyridostigmine 
derivative P1 (the IC50 for pyridostigmine was 330 nM).  
The release profile in the hybrid materials that used 
enzymes as caps via the interaction of the active site with the 
anchored inhibitors can be easily modulated by changing the 
chemical nature of the anchored inhibitor. This was clearly seen 
when the behavior of S1-AChE in the presence of DFP and 
neostigmine was compared with that of S2-AChE. For the latter 
(functionalized with P2, a neostigmine derivative), the cargo 
delivery profiles in the presence of DFP and neostigmine are 
shown in Figure 4. In the absence of DFP or neostigmine, a 
certain, yet poor, rhodamine B release was observed, which was 
also tentatively ascribed to a slow enzymatic hydrolysis of the 
P2 derivative. In contrast, the kinetic profiles obtained in the 
presence of DFP or neostigmine clearly differed. As seen in 
Figure 4, DFP was unable to induce a marked AChE 
displacement from S2-AChE and only 40% of the maximum 
rhodamine B release was observed after 20 min. However when 
neostigmine was used, nearly 90% of the dye was delivered in 
the same time. This different behavior was ascribed to the 
interaction ability of DFP and nesotigmine with AChE compared 
to that of the grafted P2. In fact, addition of DFP induced a 
moderate displacement of AChE because its IC50 value was 
higher than that of P2 and it was unable to completely detach 
AChE from the nanoparticles’ surface. Neostigmine had a similar 
IC50 to that of P2 and, for this reason, was able to compete for 
coordination with the enzyme active sites with the subsequent 
pore opening. 
 
The rhodamine B release from nanoparticles S1-AChE 
and S2-AChE in the absence and presence of inhibitors was 
tested at pH 8.0 because this is the optimal proton concentration 
for the AChE enzyme. However, the rhodamine B release from 
solid S1-AChE in the presence and absence of DFP at pH 6.0 
and 4.0 was also tested following a similar procedure to that 
described above. Solid S1-AChE was selected for this study 
because P1 has the higher IC50 value and the AChE enzyme is 
less effectively retained compared to solid S2-AChE. This 
weaker coordination of AChE to P1 could be disrupted more 
easily by changes in the environment, e.g., changes in the 
proton concentration. Moreover, DFP was selected for its 
weaker interaction with AChE compared with neostigmine. The 
Table 3. The IC50 values from the bibliography of the most relevant AChE 
inhibitors tested or grafted on solids.
[35,37–40]
 
Compound IC50 (nM) 
Pyridostigmine (P1 precursor) 330 










cargo release profiles at pH 4.0, 6.0 and 8.0 are shown in Figure 
5. As we can see in the figure, the delivery profiles at pH 4.0, 6.0 
and 8.0 are similar. The most remarkable difference at pH 4.0 
and 6.0 was an enhanced pore closure in the absence of DFP. 
This reduction in rhodamine B leakage was tentatively ascribed 
to the lower AChE enzymatic activity at an acidic pH. 
Consequently, the hydrolysis rate of P1 also lowered and the 

















Figure 5. The rhodamine B release profiles from solid S1-AChE in the 
absence and in the presence of DFP at three different pHs. The DFP response 
is drawn in black:  pH 8 (♦), 6(Х) and pH 4 (■) while blanks are drawn in 









Figure 6. Emission intensity at 572 nm (excitation at 555 nm) of the 
rhodamine B release from solids S1-AChE and S2-AChE in the presence of 
increasing amounts of neostigmine and DFP (measured 15 min after addition).  
 
After assessing the cargo delivery behavior of 
nanoparticles S1-AChE and S2-AChE with DFP and 
neostigmine, studies of the payload delivery in the presence of 
increasing amounts of both inhibitors were carried out. The 
underlying idea was to assess the minimum quantity of DFP or 
neostigmine that induced pore opening and rhodamine B 
release. The corresponding titration profiles obtained for both 
solids with DFP and neostigmine are shown in Figure 6. From 
these graphics, the limit of detections (LOD) to detect DFP and 
neostigmine were calculated and are included in Table 4. 
 
From the profiles shown in Figure 6 and from the values of 
Table 4, the LOD for neostigmine and DFP in both solids clearly 
related with the affinity of neostigmine and DFP to coordinate 
with AChE. When dealing with nanoparticles S1-AChE, the 
affinity of P1 to AChE was relatively weak and could be easily 
disrupted upon the addition of DFP and neostigmine. Moreover, 
neostigimine has a stronger affinity to AChE (IC50 of 2 nM) than 
DFP (an IC50 of 120 nM) and, consequently, a smaller amount of 
the former was needed to induce rhodamine B release. With 
neostigmine, a concentration as low as 110 nM was able to 
displace AChE from the surface of S1-AChE, whereas 
rhodamine B release was not seen for DFP until a 3 M 
concentration was reached. A similar trend was observed with 
solid S2-AChE, but in this case the amount of neostigmine and 
DFP that induced pore opening was bigger (compared with solid 
S1-AChE) due to the stronger affinity of P2 to AChE compared 
with P1. The LOD for neostigmine and DFP using S2-AChE 
were 20 M and 200 M, respectively. Besides, the LOD 
measured for DFP and neostigmine using S1-AChE and S2-
AChE nanoparticles are similar to those obtained for other 
sensory systems described in the literature (see Supporting 
Information).   
The above-indicated studies clearly demonstrated that 
AChE displacement, and pore opening, from the surface of S1-
AChE and S2-AChE were the result of competition between the 
grafted (P1 and P2) and free inhibitors (neostigmine and DFP) to 
coordinate with the enzyme’s active sites.  
 
Selectivity studies of nanoparticles S1-AChE and S2-AChE: 
After assessing the opening behavior of S1-AChE and S2-AChE 
in the absence and presence of neostigmine and DFP, we paid 
attention to study the response of both solids in the presence of 
other chemical species. For this study we selected the following 
as potential AChE inhibitors and substrates; neostisgmine (NG), 
pyridostigmine (PG), acetylcholine (ACh), acetylthiocholine 
(ASCh), diisopropylfluorophosphate (DFP), 
diethylchlorophosphate (DCP), diethylcyanophosphonate 
(DCNP), parathion (Pthion), paraoxon (Pox),dimethylmethyl 
phosphonate (OP-1), diethyl (2-cyanoethyl)phosphonate (OP-2), 
diethyl (methylthiomethyl) phosphonate (OP-3), dimethyl 
chlorothiophosphate (OP-4) and  ethyl dichlorophosphate (OP-5). 
Neostigmine and pyridostigmine are potent inhibitors of AChE, 
whereas ACh and ASCh are the natural substrates of the 
enzyme. DFP, DCP and DCNP are nerve agent simulants[41] and 
OP1-OP5 are a family of organophosphates and phosphonates. 
Table 4. Minimal  neostigmine and DFP concentrations that induced the 
pore opening of  nanoparticles S1-AChE and S2-AChE  
Solid Neostigmine (µM ) DFP (µM) 
S1-AChE 0.11 3 
S2-AChE 20 200 






Finally, parathion is a commonly used pesticide and paraoxon is 
its degradation product.[42] 
In a typical experiment, the release of rhodamine B from 
nanoparticles S1-AChE and S2-AChE in the presence of these 
chemicals at the 5 mM concentration and after 15 min in TRIS 
buffer at pH 8.0 was tested. The obtained results are shown in 
Figure 7.  
 
Figure 7. Emission intensity of rhodamine B at 572 nm (excitation at 555 nm) 
released from solid S1-AChE (dark gray bars) or S2-AChE (light gray bars) 
(TRIS 100 mM, pH 8.0) in the presence of the substrates, inhibitors and 
potential interfering agents of AChE (5mM) 15 min after addition. 
 
As a general trend, the fluorogenic response in S1-AChE 
selectivity terms was slightly better than that observed for S2-
AChE. This fact is directly related with the strong coordinating 
ability of P2 with AChE compared with P1. As seen in Figure 7, 
neostigmine, pyridostigmine, DFP and paraoxon induced the 
most marked rhodamine B release from both materials. This 
observation is clearly related with the fact that these chemicals 
display the highest affinities to the AChE enzyme. In addition, 
acetylcholine and acetylthiocholine were able to induce a 
moderate rhodamine B release (higher for S2-AChE than for S1-
AChE), whereas OP1-OP5 induced a very poor payload delivery, 
which was tentatively ascribed to their low affinity to the AChE 
enzyme. 
The results shown in Figure 7 suggest that S1-AChE and 
S2-AChE might be used for the selective fluorogenic detection 
of a certain chemical compound in a family of related derivatives. 
For instance, it is noteworthy that from all the tested nerve agent 
simulants, only DFP induced remarkable pore opening in both 
nanoparticles, whereas the response obtained with the DCP and 
DCNP simulants was much weaker. This fact indicates a 
possible use of S1-AChE and S2-AChE for the selective 
fluorogenic sensing of DFP.[33] Moreover it is also of interest that 
both nanoparticles were able to fluorimetrically differentiate 
between paraoxon and parathion. Paraoxon induced marked 
rhodamine B release, whereas the parathion response was 
weaker. The selective detection of paraoxon is interesting 
because this toxic chemical is quickly produced by air-induced 
parathion oxidation.[43] 
Conclusions 
To summarize, we report herein the preparation of two different 
mesoporous silica nanoparticles loaded with rhodamine B (as a 
model fluorophore) and capped with AChE through the formation 
of supramolecular complexes with two grafted derivatives of 
well-known enzyme inhibitors (pyridostigmine and neostigmine). 
Both nanoparticles remained closed and a poor rhodamine B 
release was observed. However in the presence of neostigmine 
and DFP, AChE was detached from the nanoparticle surface 
with the subsequent rhodamine B release. The amount of 
rhodamine B release clearly related with the affinity of the 
inhibitor to AChE’s active sites; i.e. the better the affinity to the 
enzyme, the smaller the quantity needed to induce AChE 
detachment. It is also proposed that these capped nanoparticles 
could be used in sensing protocols because they are able to 
differentiate between DFP and other nerve agent simulants (e.g., 
DCP and DCNP). Paraoxon can also be differentiated from its 
precursor parathion. These sensing features open up the 
possibility of using these, or similar nanoparticles, to design 
chromo-fluorogenic probes for these chemical species. 
Moreover in a wider context, the results presented herein may 
pave a new way to develop MSNs-based sensing systems. The 
approach we have followed is general and similar materials 
capped with other well-known enzymes can be developed to 
obtain a family of gated systems that can be selectively opened 
in the presence of inhibitors of target enzymes.  
Experimental Section 
General techniques: Powder X-ray diffraction (PXRD), 
thermogravimetric analyses (TGA), elemental analyses, transmission 
electron microscopy (TEM), N2 adsorption-desorption, UV-visible (UV-vis) 
and fluorescence spectroscopy were employed to characterize the 
synthesized materials. PXRD measurements were taken by a D8 
Advance diffractometer using CuKα radiation (Philips, Amsterdam, The 
Netherlands). Thermogravimetric analyses were carried out on a 
TGA/SDTA 851e balance (Mettler Toledo, Columbus, OH, USA) in an 
oxidizing atmosphere (air, 80 mL min-1) with a heating program: gradient 
of 393-1273 K at 10°C min-1, followed by an isothermal heating step at 
1273°C for 30 min. The TEM images were obtained with a 100 kV CM10 
microscope (Philips). N2 adsorption-desorption isotherms were recorded 
with a Tristar II Plus automated analyzer (Micromeritics, Norcross, GA, 
USA). Samples were degassed at 120°C in vacuum overnight. Specific 
surface areas were calculated from the adsorption data within the low 
pressure range using the Brunauer, Emmett and Teller (BET) model. 
Pore size was determined following the Barret, Joyner and Halenda 
(BJH) method. Fluorescence spectroscopy measurements were taken on 
a Felix 32 Analysis, version 1.2 (Build 56, Photon Technology 
International, Birmingham, NJ, USA) and by a JASCO FP-8500 
spectrophotometer. 
Chemicals: Tetraethylorthosilicate (TEOS), n-cetyltrimethylammonium 
bromide (CTAB), sodium hydroxide, (3-isocyanatopropyl)triethoxysilane, 
3-hydroxypyridine, 3-(dimethylamino)phenol, methylene iodide, 
triethylamine, rhodamine B, tris(hidroxymethyl)aminomethane (TRIS), 
hydrochloric acid, neostigmine bromide, pyridostigmine bromide, 
parathion, paraoxon, acetylcholine, acetylthiocholine, 






diisopropylfluorophosphate (DFP), diethyl chlorophosphate (DCP), 
diethyl cyanophosphonate (DCNP), dimethylmethyl phosphonate (OP-1), 
diethyl (2-cyanoethyl) phosphonate (OP-2), diethyl (methylthiomethyl) 
phosphonate (OP-3), dimethyl chlorothiophosphate (OP-4) and  ethyl 
dichlorophosphate (OP-5) were purchased from Sigma-Aldrich química 
(Madrid, Spain). All the products were used as received. 
Synthesis of mesoporous silica nanoparticles: NaOH (2.00 mol L-1, 
3.5 mL) was added to a solution of CTAB (1.00 g, 2.74 mmol) in 
deionized H2O (480 mL). The solution temperature was adjusted to 80°C 
and then TEOS (5.00 mL, 2.57 × 10-2 mol) was added drop-wise to the 
surfactant mixture. The mixture was stirred for 2 h to give a white 
precipitate. The solid was isolated by centrifugation and washed with 
deionized H2O and EtOH, and then dried at 60°C for 12 h to give MCM-
41. In order to remove the template phase, nanoparticles were calcined 
at 550°C in an oxidizing atmosphere. 
Synthesis of P1: 3-hydroxypyridine (1a, 0.5 g, 5.26 mmol) was 
dissolved in CH3CN (20 mL) and then (3-isocyanatopropyl)triethoxysilane 
(1b, 1.3 mL, 5.26 mmol) was added to the solution. A catalytic amount of 
triethylamine (110 µL) was added. The mixture was kept under stirring at 
room temperature for 4 h. Intermediate product 1c was isolated by 
evaporating the solvent in a rotary evaporator. In the final step, 1c (2.1 g, 
5.26 mmol) was dissolved in CH3CN (15 mL) and reacted with methylene 
iodide (3.3 mL, 52 mmol) for 20 h. Final product P1 (1.03 g, 4.95 mmol, 
94%) was obtained by evaporating the solvent and methylene iodide 
using a rotary evaporator. 1H NMR (400 MHz, CDCl3) δ 9.09 (br m, 1H), 
9.07 (s, 1H), 8.33 (dd, 1H), 8.10 (t, 1H), 6.31 (br s, 1H), 4.68 (s, 3H), 3.84 
(q, 6H), 3.29 (t, 2H), 1.75 (m, 2H), 1.24 (t, 9H), 0.69 (t, 2H). 13C NMR 
(101 MHz, CDCl3) δ 151.5, 150.7, 138.9, 137.8, 128.6, 128.2, 58.6, 50.1, 
43.9, 22.7, 18.3, 7.7. HRMS-EI m/z: calcd for C9H21NO3Si 219.1291; 




Synthesis of P2: 3-(dimethylamino)phenol (2a, 0.5 g, 3.64mmol) was 
dissolved in CH3CN (20 mL) and then (3-isocyanatopropyl)triethoxysilane 
(2b, 0.9mL, 3.64 mmol) was added to the solution. A catalytic amount of 
triethylamine (110 µL) was added. The mixture was kept under stirring at 
room temperature for 4 h. Intermediate product 2c was isolated by 
evaporating the solvent in a rotary evaporator. In the final step, 2c (1.56 
g, 3.64 mmol) was dissolved in CH3CN (15 mL) and reacted with 
methylene iodide (3.3 mL, 52 mmol) for 20 h. Final product P2 (1.03 g, 
2.47 mmol, 68%) was obtained by evaporating the solvent and 
methylene iodide using a rotary evaporator. 1H NMR (400 MHz, CDCl3) δ 
7.78 (d t, 1H), 7.61 (t, 1H), 7.55 (t,1H), 7.27 (d t, 1H), 5.69 (s, 1H), 3.91 
(s,3H), 3.77 (q,6H), 3.20 (t, 2H), 1.66 (m, 2H), 1.17 (t, 9H), 0.62 
(t ,3H).13C NMR (101 MHz, CDCl3) δ 151.5, 150.7, 138.9, 137.8, 128.6, 
128.2, 58.6, 50.1, 43.9, 22.7, 18.3, 7.7. HRMS-EI m/z: calcd for 
C19H35N2O5Si
+: 399.2310; found: 399.2419 
Synthesis of S1 and S2: In a typical synthesis, the calcined MSNs (200 
mg) and rhodamine B (76.64 mg, 0.16 mmol) were suspended in CH3CN 
(10 mL). The suspension was stirred at room temperature for 24 h in 
order to load the MCM-41 pores. P1 (193 mg, 0.2 mmol) or P2 (106 mg, 
0.2 mmol) were then added, and the final suspension was stirred at room 
temperature for 5.5 h. The resulting pink solid (S1 or S2) was isolated by 
centrifugation, rinsed 3 times with deionized water and with CH3CN (5 
mL), and then dried at 38°C for 18 h. 
Synthesis of S1-AChE and S2-AChE: In a typical experiment S1 or S2 
(750 µg) was suspended in TRIS buffer (450 µL, 100 mM, pH = 8.0) and 
AChE enzyme (300 µL, 2.5 µM) was added. The mixture was stirred for 
30 min and then washed 3 times with TRIS buffer (1 mL, 100 mM, pH = 
8.0) to eliminate the residual dye and the unattached enzyme. 
Enzyme activity assay: Acetylcholinesterase activity on S1-AChE and 
S2-AChE was checked by Ellman’s assay. The test is based on the fact 
that thiols react with Ellman’s reagent (5,5’-dithiobis(2-nitrobenzoic acid), 
DTNB) by cleaving the disulfide bond to give 2-nitro-5-thiobenzoate 
(TNB2-). This TNB2- has a characteristic yellow color that can be 
monitored by UV-visible spectrophotometry. Acetylthiocholine is used as 
the enzyme substrate which, when hydrolyzed, produces the resulting 
thiocholine as the thiol-containing molecule. In a typical assay, 900 µL of 
100 mM sodium phosphate buffer (pH 7.5), 30 µL 10 mM DTNB solution 
and 12 µL of acetylthiocholine (75 mM) were placed in a quartz cuvette. 
Then, 6 µL of either buffer (for blank) or S1-AChE/S2-AChE 
nanoparticles (2.7 mg·mL-1) were added. The mixture was shaken and 
absorbance at 412 nm was monitored. 
Acetylcholinesterase activity on S1-AChE and S2-AChE was estimated 




where Δ is the slope of the graph (min-1), VT is the total volume in the 
cuvette, ɛTNB is the molar extinction of TNB
2- at 412 nm (13,700 M-1cm-1), 
l is the optical path in the cuvette (1 cm) VNPs is the volume of 
nanoparticles added (mL) and CNPs is the concentration of the 
nanoparticles suspension added (g/mL). 
The release experiments of solid S1-AChE and S2-Ach in the 
presence of neostigmine and DFP: To investigate the gating properties 
of the solids, 750 μg of nanoparticles were suspended in 600 µL of TRIS 
buffer (100 mM, pH 8.0) and separated into three aliquots of 200 µL. 
Both samples were filled to a volume of 1250 µL with the same buffer. 
Next 3 µL of DFP were added to one aliquot and filled until a final volume 
of 1300 µL. For neostigmine, 50 µL of solution were directly added. 
Simultaneously, 50 µL of water (milliQ grade) were added to the 
remaining aliquot in each case. Both suspensions were stirred at 25ºC for 
90 min. Aliquots of 150 µL were taken at several times and centrifuged 
for 2 min at 12000 rpm (to remove the solid) and the fluorescence of the 
released rhodamine B was measured at 575 nm (ʎexc = 555 nm). The 
same procedure was used for the release experiments carried out at pH 
6.0 (100 mM MES buffer) and 4.0 (100 mM acetic acid/sodium acetate 
buffer).  
The calibration curve of S1-AChE and S2-AChE with DFP or 
neostigmine: In order to carry out these experiments, 500 µg of S1-
AChE or S2-AChE were suspended in 750 µL of TRIS buffer (100 mM, 
pH 8.0) and divided into 15 aliquots of 50 µL each. Several water 
solutions of DFP or neostigmine, which fell within a range from 0.06 to 
10000 µM, were prepared and, instantaneously, 150 µL of each solution 
were added to the aliquots and stirred for 15 min. One aliquot was 
reserved to add 150 µL of water (milliQ grade) as a blank. Then 
suspensions were centrifuged for 2 min at 12000 rpm (to remove the 
solid) and the fluorescence of the released rhodamine B was measured 
at 575 nm (ʎexc= 555 nm). 
The selectivity studies with S1-AChE and S2-AChE: In order to test 
the selectivity of the solids, 500 µg of nanoparticles were suspended in 1 
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100 µL. Several water solutions of different organophosphorus 
compounds (DFP, DCP, DCNP, Pthion, Pox, OP1, OP2, OP3, OP4, OP5, 
ACh, ASCh, PG and NG) were prepared at a concentration of 5 mM. 
Next 200 µL of the prepared solutions were added to each aliquot to 
obtain a final concentration of 1000 ppm. One aliquot was reserved to 
add 200 µL of water (milliQ grade) as a blank. After 15 min of stirring, 
samples were centrifuged for 2 min at 12000 rpm (to remove the solid) 
and the fluorescence of the released rhodamine B was measured at 575 
nm (exc= 555 nm). 
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